We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find University Hospitals Doctors
Wei Xiong, MD

Wei Xiong, MD

  • Specialty: Neurology, Neurology-Vascular Neurology
    View Expertise
  • Languages Spoken: English, Chinese, Mandarin Chinese

Biography: Wei Xiong, MD

Expertise

  • Cardiac Arrest
  • Hypothermia
  • Neuro Critical Care
  • Stroke
  • Vascular Neurology

Titles

  • Associate Professor, CWRU School of Medicine

Certifications & Memberships

  • Neurology - American Board of Psychiatry and Neurology
  • Neurocritical Care - United Council for Neurologic Subspecialties

Education

Fellowship | Neurocritical Care
Neurocritical Care - Johns Hopkins Hospital (2009 - 2011)

Residency | Neurology
Neurology - Johns Hopkins Hospital (2006 - 2009)

Internship | Internal Medicine
Internal Medicine - University Of Maryland Medical Center (2005 - 2006)

Medical Education
Case Western Reserve University School Of Medicine (2005)

Undergraduate
The Ohio State University (2001)

About

Dr. Wei Xiong is a staff Neurointensivist at the Reinberger Neuroscience Intensive Care Unit at University Hospitals Cleveland Medical Center in Cleveland, Ohio. He is the Assistant Dean for Clerkship Education - UH for the Case Western Reserve University School of Medicine. He is also an Associate Professor of Neurology at Case Western Reserve University School of Medicine, where he serves as Director of the Core Neuroscience Clerkship for 3rd-year medical students. Dr. Xiong is a Stroke Neurologist for the Cerebrovascular Center of University Hospitals' Neurological Institute.

Dr. Xiong's clinical interests include neurocritical care, acute ischemic stroke, acute intracerebral hemorrhage, subarachnoid hemorrhage, intravenous and intra-arterial thrombolytic therapy, tele-stroke, status epilepticus, and prognostication after cardiac arrest. His research interests include coma recovery after cardiac arrest, neurophysiology signals, their potential use for prognostication and optimization of neuroprotective therapies, management of Takotsubo cardiomyopathy in patients with aneurysmal subarachnoid hemorrhage, and utilization of ICU resources in patients with primary intracerebral hemorrhages. He is actively involved in the education of medical students in their pre-clinical and clinical years and residents and fellows.

Dr. Xiong graduated summa cum laude with a B.S. degree in Electrical Engineering from The Ohio State University in 2001. He then earned his medical degree from the Case Western Reserve University School of Medicine in 2005. As part of his graduate medical education, he completed an Internal Medicine internship at the University of Maryland. He then went on to Johns Hopkins University for Neurology Residency, serving as an Administrative Chief Resident during his last year. Dr. Xiong stayed at Johns Hopkins for fellowship training in Neurocritical Care, finishing in 2011. He is board-certified in Neurology and Neurocritical Care and a member of the American Academy of Neurology and the Neurocritical Care Society. 

In his spare time, he enjoys nature and outdoor activities.

Research & Publications

Research Interests

Neurocritical care, Medical Education, Acute intracerebral hemorrhage, Acute ischemic stroke, Prognostication and optimization of neuroprotective therapies, Intensive care monitoring, Neurophysiology signals in coma

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, Wei Xiong did not disclose any Outside Relationships with Industry.